Nontuberculous Mycobacterial (NTM) Lung Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
-1.jpg)
Non-tuberculosis mycobacterial (NTM) lung infections are less prevalent than infections caused by Mycobacterium tuberculosis. The transmission of NTM occurs through the inhalation of aerosolized droplets containing the infectious agents. Risk factors for NTM transmission include proximity living, coughing, and failure to use facial masks. Factors such as advanced age, immunosuppression, and corticosteroid usage increase the likelihood of acquiring NTM microorganisms. Following the entry into the body, NTM microorganisms predominantly settle in the lower airways and may induce an inflammatory response characterized by an influx of lymphocytes. This immune response releases cytokines and other mediators, resulting in a pneumonia-like infectious process. Common symptoms of NTM lung infections, such as fever, weight loss, night sweats, decreased appetite, and energy loss, are often nonspecific and vague. The prognosis of NTM lung infections is generally uncertain. Patients with compromised...